Lenabasum Improved Skin Symptoms, in Small Dermatomyositis Trial
In the phase 2 trial, skin biopsies before and after treatment showed significant reductions in inflammatory cytokines relevant to dermatomyositis pathogenesis.
Source: medscape.com
Stay updated with breaking news from Diffuse Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the phase 2 trial, skin biopsies before and after treatment showed significant reductions in inflammatory cytokines relevant to dermatomyositis pathogenesis.